Massive study tests Weight-Loss Drug's power to prevent heart attacks and death

This large, completed study looked back at health records of over 285,000 overweight or obese adults to see if taking the weekly medication semaglutide was linked to fewer serious heart problems. It focused on three groups: people with existing heart failure, people with heart artery disease, and people at high risk for developing heart disease. The main goal was to understand if this weight-management drug helps control major cardiovascular risks in real-world settings.